Literature DB >> 31171988

BIOTRANSFORMATION OF HYDRAZINE DERVATIVES IN THE MECHANISM OF TOXICITY.

Birandra K Sinha1, Ronald P Mason1.   

Abstract

Hydrazine derivatives are environmental and food pollutants but are also important because of their use in medicine for the treatment of tuberculosis and cancer. However, hydrazines also pose significant health risks to humans as they are mutagenic and carcinogenic. This review examines various metabolic pathways (enzymatic and non-enzymatic) of hydrazines for the formation of reactive species that bind to cellular macromolecules and lead to cellular dysfunction. It is believed that this biotransformation is responsible for the pharmacology and pathophysiology of hydrazine derivatives.

Entities:  

Year:  2014        PMID: 31171988      PMCID: PMC6548516          DOI: 10.4172/2157-7609.1000168

Source DB:  PubMed          Journal:  J Drug Metab Toxicol


  58 in total

1.  PRELIMINARY CLINICAL RESULTS WITH A NEW ANTITUMOR AGENT RO 4-6467 (NSC-77213).

Authors:  G MARTZ; A D ALESSANDRI; H J KEEL; W BOLLAG
Journal:  Cancer Chemother Rep       Date:  1963-12

Review 2.  Free radicals, antioxidants, and human disease: where are we now?

Authors:  B Halliwell; J M Gutteridge; C E Cross
Journal:  J Lab Clin Med       Date:  1992-06

3.  Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats.

Authors:  N D Vaziri; X Q Wang; F Oveisi; B Rad
Journal:  Hypertension       Date:  2000-07       Impact factor: 10.190

4.  Cellular toxicity of hydrazine in primary rat hepatocytes.

Authors:  Saber M Hussain; John M Frazier
Journal:  Toxicol Sci       Date:  2002-10       Impact factor: 4.849

5.  Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.

Authors:  Blanca Segura-Pacheco; Catalina Trejo-Becerril; Enrique Perez-Cardenas; Lucia Taja-Chayeb; Ignacio Mariscal; Alma Chavez; Carmen Acuña; Ana Maria Salazar; Marcela Lizano; Alfonso Dueñas-Gonzalez
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

6.  Effects of prenatal procarbazine administration on intrauterine development in rats.

Authors:  F A Malek; K U Möritz; J Fanghänel
Journal:  Ann Anat       Date:  2003-04       Impact factor: 2.698

7.  Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.

Authors:  Helen J Knowles; Ya-Min Tian; David R Mole; Adrian L Harris
Journal:  Circ Res       Date:  2004-06-10       Impact factor: 17.367

8.  Risk assessment of high-energy chemicals by in vitro toxicity screening and quantitative structure-activity relationships.

Authors:  Steven Trohalaki; Robert J Zellmer; Ruth Pachter; Saber M Hussain; John M Frazier
Journal:  Toxicol Sci       Date:  2002-08       Impact factor: 4.849

9.  Hydralazine target: from blood vessels to the epigenome.

Authors:  Claudia Arce; Blanca Segura-Pacheco; Enrique Perez-Cardenas; Lucia Taja-Chayeb; Myrna Candelaria; Alfonso Dueñnas-Gonzalez
Journal:  J Transl Med       Date:  2006-02-28       Impact factor: 5.531

10.  Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors.

Authors:  Jean-Pierre Armand; Vincent Ribrag; Jean-Luc Harrousseau; Lauren Abrey
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

View more
  4 in total

1.  Towards N-N-Doped Carbon Dots: A Combined Computational and Experimental Investigation.

Authors:  Chiara Olla; Stefania Porcu; Francesco Secci; Pier Carlo Ricci; Carlo Maria Carbonaro
Journal:  Materials (Basel)       Date:  2022-02-16       Impact factor: 3.623

2.  Role of Oxygen and Nitrogen Radicals in the Mechanism of Anticancer Drug Cytotoxicity.

Authors:  Birandra Kumar Sinha
Journal:  J Cancer Sci Ther       Date:  2020-01-24

Review 3.  Dietary Energy Partition: The Central Role of Glucose.

Authors:  Xavier Remesar; Marià Alemany
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

4.  Phthalimide conjugation turns the AIE-active tetraphenylethylene unit non-emissive: its use in turn-on sensing of hydrazine in solution and the solid- and vapour-phase.

Authors:  Sharanabasava D Hiremath; Ram U Gawas; Dharmendra Das; Viraj G Naik; Akhil A Bhosle; Vishnu Priya Murali; Kaustabh Kumar Maiti; Raghunath Acharya; Mainak Banerjee; Amrita Chatterjee
Journal:  RSC Adv       Date:  2021-06-15       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.